Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Pharmacoeconomics
|
July 13, 2026
Optimisation or Restriction? Unpacking the Logic Behind NICE Decisions
Nadine Henderson, Brittany Darrow, Phill O'Neill, et al.
Journal of Comparative Effectiveness Research
|
March 6, 2015
Futurescapes: expectations in Europe for relative effectiveness evidence for drugs in 2020
Adrian Towse, Martina Garau, Penny Mohr, et al.
Journal of Comparative Effectiveness Research
|
March 3, 2015
The future of comparative effectiveness and relative efficacy of drugs: an international perspective
Donna A Messner, Adrian Towse, Penny Mohr, et al.
International Journal of Technology Assessment in Health Care
|
February 13, 2016
IS THE LINK BETWEEN HEALTH AND WEALTH CONSIDERED IN DECISION MAKING? RESULTS FROM A QUALITATIVE STUDY
Martina Garau, Koonal Kirit Shah, Priya Sharma, et al.
BMJ (Clinical Research Ed.)
|
December 17, 2004
Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study
A H Miners, Martina Garau, Dogan Fidan, et al.
Personalized Medicine
|
May 23, 2018
Can and should value-based pricing be applied to molecular diagnostics?
Martina Garau, Adrian Towse, Louis Garrison, et al.
Pharmacoeconomics - Open
|
April 7, 2018
Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders' Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)
Martina Garau, Grace Hampson, Nancy Devlin, et al.
Orphanet Journal of Rare Diseases
|
May 5, 2019
Comparing access to orphan medicinal products in Europe
Bernarda Zamora, Francois Maignen, Phill O'Neill, et al.
International Journal of Technology Assessment in Health Care
|
July 15, 2015
PAYER PERSPECTIVES ON FUTURE ACCEPTABILITY OF COMPARATIVE EFFECTIVENESS AND RELATIVE EFFECTIVENESS RESEARCH
Rachael Moloney, Penny Mohr, Emma Hawe, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 12, 2013
A pilot study of multicriteria decision analysis for valuing orphan medicines
Jon Sussex, Pierrick Rollet, Martina Garau, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Pharmacoeconomics
|
July 13, 2026
Optimisation or Restriction? Unpacking the Logic Behind NICE Decisions
Nadine Henderson, Brittany Darrow, Phill O'Neill, et al.
Journal of Comparative Effectiveness Research
|
March 6, 2015
Futurescapes: expectations in Europe for relative effectiveness evidence for drugs in 2020
Adrian Towse, Martina Garau, Penny Mohr, et al.
Journal of Comparative Effectiveness Research
|
March 3, 2015
The future of comparative effectiveness and relative efficacy of drugs: an international perspective
Donna A Messner, Adrian Towse, Penny Mohr, et al.
International Journal of Technology Assessment in Health Care
|
February 13, 2016
IS THE LINK BETWEEN HEALTH AND WEALTH CONSIDERED IN DECISION MAKING? RESULTS FROM A QUALITATIVE STUDY
Martina Garau, Koonal Kirit Shah, Priya Sharma, et al.
BMJ (Clinical Research Ed.)
|
December 17, 2004
Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study
A H Miners, Martina Garau, Dogan Fidan, et al.
Personalized Medicine
|
May 23, 2018
Can and should value-based pricing be applied to molecular diagnostics?
Martina Garau, Adrian Towse, Louis Garrison, et al.
Pharmacoeconomics - Open
|
April 7, 2018
Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders' Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)
Martina Garau, Grace Hampson, Nancy Devlin, et al.
Orphanet Journal of Rare Diseases
|
May 5, 2019
Comparing access to orphan medicinal products in Europe
Bernarda Zamora, Francois Maignen, Phill O'Neill, et al.
International Journal of Technology Assessment in Health Care
|
July 15, 2015
PAYER PERSPECTIVES ON FUTURE ACCEPTABILITY OF COMPARATIVE EFFECTIVENESS AND RELATIVE EFFECTIVENESS RESEARCH
Rachael Moloney, Penny Mohr, Emma Hawe, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 12, 2013
A pilot study of multicriteria decision analysis for valuing orphan medicines
Jon Sussex, Pierrick Rollet, Martina Garau, et al.
Page
of 2